Latest News

Healthcare distributor and services company McKesson (NYSE:MCK) beat Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q2 2027), with revenue up...

Revenue climbed 26% as the company eyes positive adjusted EBITDA by 2027.

Oil and gas producer APA Corporation (NASDAQ:APA) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 51% year on year to $...

Mortgage insurer MGIC Investment (NYSE:MTG) met Wall Street’s revenue expectations in Q3 2026, but revenue edged lower by 1.8% year on year to $299.1 million...

Business management solutions provider Barrett Business Services (NASDAQ:BBSI) reported Q3 2026 results exceeding the market’s revenue expectations, with rev...

Natural gas producer Comstock Resources (NYSE:CRK) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 14.9% year on year to $384.4 millio...

The impacts of tariffs and trade wars brought neocloud stocks to a low point in 2025 before potent rallies put them back in the spotlight on Wall Street. The end of this year may follow that same pattern.

American firearm manufacturing company Ruger (NYSE:RGR) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 16.5% year on year t...

Trio output climbed 19% as Moab harvest timing shifted.

Mortgage investment firm Ellington Financial (NYSE:EFC) announced better-than-expected revenue in Q3 2026, with revenue up 42.3% year on year to $117.7 milli...

Theater company AMC Entertainment (NYSE:AMC) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 31.6% year on year to $1.71...

Record cement volumes offset diesel costs as wallboard demand stays soft.

Medical equipment and services company Steris (NYSE:STE) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 8.8% ye...

Pacific Biosciences of California (NASDAQ:PACB) reported 6% revenue growth for the third quarter of 2026 as customers adopted its SPRQ-Nx sequencing chemistry, though consumables revenue declined from a year earlier and academic funding constraints continued to weigh on instrument purchases in the A

ADC Therapeutics (NYSE:ADCT) outlined new lymphoma data and plans for further studies of its cancer drug ZYNLONTA, while reporting preliminary third-quarter sales of approximately $21 million and an expected cash runway into 2029. The company said Wednesday that five oral presentations and multiple

Grand Canyon Education (NASDAQ:LOPE) reported 2.4% revenue growth for the third quarter of 2026, but weaker-than-expected new enrollments at Grand Canyon University’s traditional campus prompted the company to lower its revenue outlook and projected operating margin. Service revenue rose to $267.3

LegalZoom.com (NASDAQ:LZ) lowered its full-year adjusted earnings outlook after a tougher customer acquisition environment weighed on business formations in the third quarter, even as subscription revenue continued to grow. The company reported third-quarter revenue of $195 million, up 3% from a ye

Myriad Genetics (NASDAQ:MYGN) reported third-quarter revenue of $202.7 million, down 1% from a year earlier, as growth in cancer and mental health testing was offset by a decline in its prenatal business. The company raised its full-year revenue outlook and said early efforts to address reimbursemen

Cytek Biosciences (NASDAQ:CTKB) reported third-quarter 2026 revenue of $53.2 million, up 2% from a year earlier, as growth in the U.S. and demand for its high-end instruments helped offset weakness in Asia-Pacific. The flow cytometry company narrowed its full-year revenue guidance to $208 million t

Fatpipe Inc/UT (NASDAQ:FATN) reported a 22% increase in second-quarter revenue and a return to profitability, as recurring billings rose and the networking company began selling a new network-monitoring product. Revenue was approximately $4.83 million for the quarter ended September 30, 2026, Chief

Energy Recovery (NASDAQ:ERII) said desalination megaproject contracting has rebounded in the Middle East, with more than $30 million in new contracts signed over the past 30 days and a record project pipeline of about $525 million. Interim President and CEO Alex Buehler said construction has resume

ADMA Biologics (NASDAQ:ADMA) raised its minimum full-year earnings expectations after third-quarter profit rose on stronger sales of ASCENIV and improved manufacturing yields, even as competitive pressure weighed on its BIVIGAM product. The company reported third-quarter revenue of $141.1 million,

American Bitcoin (NASDAQ:ABTC) reported third-quarter net income of approximately $126 million, reversing a second-quarter loss, as gains on its Bitcoin holdings offset pressure on mining margins from higher energy costs. The company mined approximately 891 Bitcoin during the quarter, down from 932

Don't miss out on a big opportunity.

Maritime shipping company Genco (NYSE:GNK) reported Q3 2026 results topping the market’s revenue expectations, with revenue up 176% year on year to $151.9 mi...